Optimizing the use of continuous glucose monitoring in young children with type 1 diabetes with an adaptive study

Cari Berget1, Kimberly A Driscoll1, Ann Lagges2

  • 1University of Colorado Denver, School of Medicine, Barbara Davis Center for Childhood Diabetes, United States of America.

Insights

This study introduces novel behavioral interventions to help parents manage type 1 diabetes (T1D) in young children. These interventions aim to improve glucose control, device adherence, and reduce parental stress.

Area of Science:

  • Pediatric Endocrinology
  • Behavioral Science
  • Diabetes Management

Background:

  • Managing type 1 diabetes (T1D) in young children presents unique developmental challenges for parents, often leading to psychosocial distress.
  • Low adherence to diabetes devices and suboptimal glucose control are prevalent in this pediatric population.

Purpose of the Study:

  • To test four interventions combining tailored behavioral support and education to optimize diabetes device use.
  • To improve glucose control and reduce psychosocial distress in parents of young children with T1D.
  • To describe the development and pilot testing of these interventions.

Main Methods:

  • Development of four distinct behavioral interventions: two focused on glucose control, two on device adherence.
  • A pilot test of the interventions.
  • A large-scale, randomized trial with 90 participants using a sequential multiple assignment randomization trial (SMART) design.

Main Results:

  • Pilot test results of the developed behavioral interventions will be presented.
  • The study will evaluate the effectiveness of the intervention strategy through a SMART design.

Conclusions:

  • The study aims to provide a clinically relevant evaluation of a novel intervention strategy for T1D management in young children.
  • The SMART design allows for adaptive, individualized intervention adjustments, moving beyond traditional fixed-dose approaches.

Related Concept Videos

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

Body:Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to...
243
Bioavailability Study Design: Single Versus Multiple Dose Studies01:11

Bioavailability Study Design: Single Versus Multiple Dose Studies

Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
220
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.4K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.0K
Group Design02:01

Group Design

The most basic experimental design involves two groups: the experimental group and the control group. The two groups are designed to be the same except for one difference— experimental manipulation. The experimental group gets the experimental manipulation—that is, the treatment or variable being tested—and the control group does not. Since experimental manipulation is the only difference between the experimental and control groups, we can be sure that any differences between...
10.3K
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
933